the oncogenic effect of alkylating agents , particularly that of melphalan , has been postulated as the most likely cause of myelodysplastic syndrome ( mds ) and acute leukaemia in patients with plasma cell neoplasia .
C0025241
melphalan
C0026764
plasma cell neoplasia